Global Retinal Vascular Occlusion Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 2045

Retinal Vascular Occlusion (RVO) is the build-up of blood or other fluids in the retina of the eye, which prevents it from properly filtering light caused by the blood clot.
The Americas account for a significant market share owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of ophthalmology procedures due to greater healthcare penetration in the U.S. and Canada drives the retinal vascular occlusion market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of ophthalmology procedures, especially, the retinal vascular occlusion surgery treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retinal vascular occlusion market in the US. The high development of the microsurgery field in developed regions such as the U.S. and Europe is a strong driver of the market.
In 2018, the global Retinal Vascular Occlusion market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Retinal Vascular Occlusion status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Vascular Occlusion development in United States, Europe and China.

The key players covered in this study
Regeneron Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals LLC.
Novartis AG
Pfizer, Inc.
AstraZeneca PLC.
GlaxoSmithKline PLC.
Johnson & Johnson
Teva pharmaceutical industries
Novo Nordisk
Sanofi

Market segment by Type, the product can be split into
Anti-vascular Endothelial Growth Factor (VEGF)
Corticosteroid
Anticoagulants
Fibrinolytic
Others

Market segment by Application, split into
Hospitals and Clinics
Research and Academics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Retinal Vascular Occlusion status, future forecast, growth opportunity, key market and key players.
To present the Retinal Vascular Occlusion development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Vascular Occlusion are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Retinal Vascular Occlusion Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-vascular Endothelial Growth Factor (VEGF)
1.4.3 Corticosteroid
1.4.4 Anticoagulants
1.4.5 Fibrinolytic
1.4.6 Others
1.5 Market by Application
1.5.1 Global Retinal Vascular Occlusion Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Research and Academics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Retinal Vascular Occlusion Market Size
2.2 Retinal Vascular Occlusion Growth Trends by Regions
2.2.1 Retinal Vascular Occlusion Market Size by Regions (2014-2025)
2.2.2 Retinal Vascular Occlusion Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Retinal Vascular Occlusion Market Size by Manufacturers
3.1.1 Global Retinal Vascular Occlusion Revenue by Manufacturers (2014-2019)
3.1.2 Global Retinal Vascular Occlusion Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Retinal Vascular Occlusion Market Concentration Ratio (CR5 and HHI)
3.2 Retinal Vascular Occlusion Key Players Head office and Area Served
3.3 Key Players Retinal Vascular Occlusion Product/Solution/Service
3.4 Date of Enter into Retinal Vascular Occlusion Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Retinal Vascular Occlusion Market Size by Type (2014-2019)
4.2 Global Retinal Vascular Occlusion Market Size by Application (2014-2019)

5 United States
5.1 United States Retinal Vascular Occlusion Market Size (2014-2019)
5.2 Retinal Vascular Occlusion Key Players in United States
5.3 United States Retinal Vascular Occlusion Market Size by Type
5.4 United States Retinal Vascular Occlusion Market Size by Application

6 Europe
6.1 Europe Retinal Vascular Occlusion Market Size (2014-2019)
6.2 Retinal Vascular Occlusion Key Players in Europe
6.3 Europe Retinal Vascular Occlusion Market Size by Type
6.4 Europe Retinal Vascular Occlusion Market Size by Application

7 China
7.1 China Retinal Vascular Occlusion Market Size (2014-2019)
7.2 Retinal Vascular Occlusion Key Players in China
7.3 China Retinal Vascular Occlusion Market Size by Type
7.4 China Retinal Vascular Occlusion Market Size by Application

8 Japan
8.1 Japan Retinal Vascular Occlusion Market Size (2014-2019)
8.2 Retinal Vascular Occlusion Key Players in Japan
8.3 Japan Retinal Vascular Occlusion Market Size by Type
8.4 Japan Retinal Vascular Occlusion Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Retinal Vascular Occlusion Market Size (2014-2019)
9.2 Retinal Vascular Occlusion Key Players in Southeast Asia
9.3 Southeast Asia Retinal Vascular Occlusion Market Size by Type
9.4 Southeast Asia Retinal Vascular Occlusion Market Size by Application

10 India
10.1 India Retinal Vascular Occlusion Market Size (2014-2019)
10.2 Retinal Vascular Occlusion Key Players in India
10.3 India Retinal Vascular Occlusion Market Size by Type
10.4 India Retinal Vascular Occlusion Market Size by Application

11 Central & South America
11.1 Central & South America Retinal Vascular Occlusion Market Size (2014-2019)
11.2 Retinal Vascular Occlusion Key Players in Central & South America
11.3 Central & South America Retinal Vascular Occlusion Market Size by Type
11.4 Central & South America Retinal Vascular Occlusion Market Size by Application

12 International Players Profiles
12.1 Regeneron Pharmaceuticals, Inc.
12.1.1 Regeneron Pharmaceuticals, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Retinal Vascular Occlusion Introduction
12.1.4 Regeneron Pharmaceuticals, Inc. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.1.5 Regeneron Pharmaceuticals, Inc. Recent Development
12.2 Bayer HealthCare Pharmaceuticals LLC.
12.2.1 Bayer HealthCare Pharmaceuticals LLC. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Retinal Vascular Occlusion Introduction
12.2.4 Bayer HealthCare Pharmaceuticals LLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.2.5 Bayer HealthCare Pharmaceuticals LLC. Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Retinal Vascular Occlusion Introduction
12.3.4 Novartis AG Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.3.5 Novartis AG Recent Development
12.4 Pfizer, Inc.
12.4.1 Pfizer, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Retinal Vascular Occlusion Introduction
12.4.4 Pfizer, Inc. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.4.5 Pfizer, Inc. Recent Development
12.5 AstraZeneca PLC.
12.5.1 AstraZeneca PLC. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Retinal Vascular Occlusion Introduction
12.5.4 AstraZeneca PLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.5.5 AstraZeneca PLC. Recent Development
12.6 GlaxoSmithKline PLC.
12.6.1 GlaxoSmithKline PLC. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Retinal Vascular Occlusion Introduction
12.6.4 GlaxoSmithKline PLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.6.5 GlaxoSmithKline PLC. Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Retinal Vascular Occlusion Introduction
12.7.4 Johnson & Johnson Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
12.8 Teva pharmaceutical industries
12.8.1 Teva pharmaceutical industries Company Details
12.8.2 Company Description and Business Overview
12.8.3 Retinal Vascular Occlusion Introduction
12.8.4 Teva pharmaceutical industries Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.8.5 Teva pharmaceutical industries Recent Development
12.9 Novo Nordisk
12.9.1 Novo Nordisk Company Details
12.9.2 Company Description and Business Overview
12.9.3 Retinal Vascular Occlusion Introduction
12.9.4 Novo Nordisk Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.9.5 Novo Nordisk Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Retinal Vascular Occlusion Introduction
12.10.4 Sanofi Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.10.5 Sanofi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details